Table: RaQualia Pharma -2020 group results

RaQualia Pharma

12/02/2021 06:01

Feb 12 (Reuters)- 
          RaQualia Pharma Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Dec 31, 2020    Dec 31, 2019   Dec 31, 2021     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             1.11            1.70           2.74                  
                 (-35.0 pct)    (+128.7 pct)   (+147.3 pct)              
  Operating     loss 486 mln     loss 15 mln      420 mln                
  Recurring     loss 527 mln       21 mln         427 mln                
  Net
  Net           loss 606 mln        5 mln         343 mln                
  EPS          loss 28.97 yen     0.26 yen       16.41 yen               
  EPS Diluted                     0.26 yen                               
  Ann Div            NIL             NIL            NIL                  
  -Q2 Div            NIL             NIL            NIL                  
  -Q4 Div            NIL             NIL            NIL                  
  
  NOTE - RaQualia Pharma Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T